Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework
{{output}}
Reducing the immunogenicity of animal-derived monoclonal antibodies (mAbs) for use in humans is critical to maximize therapeutic effectiveness and preclude potential adverse events. While traditional humanization methods have primarily focused on grafting anti... ...
